Fig. 1.From: Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression5mC and 5hmC profiling of bladder cancer samples at single-base resolution. A The number of significant 5mC and 5hmC differentially methylated regions (DMRs) identified in bladder cancer samples. B The genomic annotations of 5mC and 5hmC DMRs. Pathway enrichment for 5mC hyper (C) and hypo DMRs (D) in bladder cancer. Pathway enrichment for 5hmC hyper (E) and hypo DMRs (F) in bladder cancerBack to article page